Alimentiv Inc.
Clinical trials sponsored by Alimentiv Inc., explained in plain language.
-
Can healing the gut wall transform Crohn's treatment?
Disease control Recruiting nowThis study tests whether treating Crohn's disease with a goal of healing all layers of the gut wall (called transmural healing) leads to better results than treating symptoms and blood markers alone. About 304 adults with moderate to severe Crohn's will be split into two groups: …
Phase: PHASE4 • Sponsor: Alimentiv Inc. • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
New study aims to give ileostomy patients a voice in Crohn's trials
Knowledge-focused Recruiting nowThis study includes 50 adults with Crohn's disease who have a permanent ileostomy. Researchers will review routine endoscopy videos and interview participants to create new tools that measure inflammation and symptoms. The goal is to help this group be included in future clinical…
Sponsor: Alimentiv Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 01:19 UTC
-
Crohn's study asks patients: how soon do you feel better?
Knowledge-focused Recruiting nowThis study follows 300 adults with Crohn's disease who are starting standard treatments (vedolizumab or IL-23 blockers). Researchers will use patient questionnaires to measure how quickly symptoms like pain, fatigue, and mood improve. The goal is to better understand when patient…
Sponsor: Alimentiv Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 01:18 UTC
-
Can a simple test pick the best Crohn's drug? new study aims to find out.
Knowledge-focused Recruiting nowThis study compares two ways of selecting biologic treatment for adults with active Crohn's disease: using a new epigenetic test (EpiPredict) versus the usual standard of care. About 378 participants will be randomly assigned to either approach. The goal is to see if the test lea…
Phase: NA • Sponsor: Alimentiv Inc. • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC